1. Home
  2. ZSTK vs GDTC Comparison

ZSTK vs GDTC Comparison

Compare ZSTK & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZSTK

ZeroStack Corp. Common Stock

N/A

Current Price

$1.48

Market Cap

10.4M

Sector

Health Care

ML Signal

N/A

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.91

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZSTK
GDTC
Founded
2019
2018
Country
Canada
Singapore
Employees
21
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
10.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ZSTK
GDTC
Price
$1.48
$0.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.9K
35.9K
Earning Date
05-12-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.73
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$0.68
52 Week High
$11.00
$3.68

Technical Indicators

Market Signals
Indicator
ZSTK
GDTC
Relative Strength Index (RSI) 24.33 41.76
Support Level N/A $0.70
Resistance Level $5.15 $1.07
Average True Range (ATR) 0.22 0.10
MACD 0.02 -0.01
Stochastic Oscillator 14.53 45.42

Price Performance

Historical Comparison
ZSTK
GDTC

About ZSTK ZeroStack Corp. Common Stock

ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide Commercial and wholesale business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape. The other segment commercial and wholesale (Phatebo and TruHC), which sell pharmaceutical products and mix of products across multiple categories including food and beverage, cannabis accessories and technology, personal care and wellness.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: